第一单位:
Department of Neuroscience, University of Sheffield, Sheffield, UK.;Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
作者:
Sokratis,Kariotis [1]
;
Emmanuel,Jammeh [1]
;
Emilia M,Swietlik [2]
;
Josephine A,Pickworth [3]
;
Christopher J,Rhodes [4]
;
Pablo,Otero [4]
;
John,Wharton [4]
;
James,Iremonger [3]
;
Mark J,Dunning [5]
;
Divya,Pandya [6]
;
Thomas S,Mascarenhas [5]
;
Niamh,Errington [1]
;
A A Roger,Thompson [7]
;
Casey E,Romanoski [8]
;
Franz,Rischard [8]
;
Joe G N,Garcia [8]
;
Jason X-J,Yuan [9]
;
Tae-Hwi Schwantes,An [10]
;
Ankit A,Desai [10]
;
Gerry,Coghlan [11]
;
Jim,Lordan [12]
;
Paul A,Corris [12]
;
Luke S,Howard [4]
;
Robin,Condliffe [7]
;
David G,Kiely [13]
;
Colin,Church [14]
;
Joanna,Pepke-Zaba [15]
;
Mark,Toshner [2]
;
Stephen,Wort [4]
;
Stefan,Gräf [6]
;
Nicholas W,Morrell [6]
;
Martin R,Wilkins [4]
;
Allan,Lawrie [16]
;
Dennis,Wang [17]
;
UK National PAH Cohort Study Consortium
作者单位:
Department of Neuroscience, University of Sheffield, Sheffield, UK.;Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
[1]
Department of Medicine, University of Cambridge, Cambridge, UK.;Royal Papworth Hospital, Cambridge, UK.
[2]
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
[3]
National Heart and Lung Institute, Imperial College London, London, UK.
[4]
Department of Neuroscience, University of Sheffield, Sheffield, UK.
[5]
Department of Medicine, University of Cambridge, Cambridge, UK.
[6]
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.;Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.
[7]
Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
[8]
Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
[9]
Department of Medicine, Indiana University, Indianapolis, IN, USA.
[10]
Royal Free Hospital, University College London, London, UK.
[11]
Newcastle University, Newcastle, UK.
[12]
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.;Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.;Insigneo institute for In Silico Medicine, Sheffield, UK.
[13]
University of Glasgow, Glasgow, UK.
[14]
Royal Papworth Hospital, Cambridge, UK.
[15]
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. a.lawrie@sheffield.ac.uk.;Insigneo institute for In Silico Medicine, Sheffield, UK. a.lawrie@sheffield.ac.uk.
[16]
Department of Neuroscience, University of Sheffield, Sheffield, UK. dennis.wang@sheffield.ac.uk.;Department of Computer Science, University of Sheffield, Sheffield, UK. dennis.wang@sheffield.ac.uk.;Singapore Institute for Clinical Sciences, Singapore, Singapore. dennis.wang@sheffield.ac.uk.
[17]
DOI
10.1038/s41467-022-33381-y
PMID
36433938
发布时间
2025-05-30